S
SynAct Pharma AB
STO:SYNACT
SynAct Pharma AB
STO:SYNACT
Price:
17.32
SEK
Market Cap:
kr923.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Going Public Media AG
XETRA:G6P0
|
DE |
|
B
|
Brixton Metals Corp
SWB:8BX1
|
CA |
SynAct Pharma AB
Other
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
SynAct Pharma AB
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SynAct Pharma AB
STO:SYNACT
|
Other
kr90.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Biogaia AB
STO:BIOG B
|
Other
-kr5m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Other
-kr49.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Other
-kr10m
|
CAGR 3-Years
6%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Other
kr555m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
BioArctic AB
STO:BIOA B
|
Other
kr26.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
SynAct Pharma AB
Glance View
SynAct Pharma AB engages in the development of pharmaceutical drugs for the treatment of inflammatory diseases. The company is headquartered in Lund, Skane. The company went IPO on 2016-07-11. The firm is located in Lund, Sweden. The company develops medicines for acute impairment in inflammatory diseases. The firm's drug candidate AP1189 is intended for the treatment of arthritis including psoriasis arthritis.
SYNACT
Intrinsic Value
54.58
SEK
Undervaluation 68%
S
See Also
What is SynAct Pharma AB's Other?
Other
90.5m
SEK
90.5m
SEK
Based on the financial report for Dec 31, 2025, SynAct Pharma AB's Other amounts to 90.5m SEK.
